Tokyo Tape
Sign in
← Hyuga Primary Care

Quarterly report · Q2

7133.TEDINET S100S8NI
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥3.9bn2023-04-01 → 2023-09-30StandaloneNet sales
Revenue¥6.7bn2022-04-01 → 2023-03-31StandaloneNet sales (5-year summary)
Revenue¥3.2bn2022-04-01 → 2022-09-30StandaloneNet sales
Operating income¥201m2023-04-01 → 2023-09-30StandaloneOperating income
Operating income¥255m2022-04-01 → 2022-09-30StandaloneOperating income
Ordinary income¥200m2023-04-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥558m2022-04-01 → 2023-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥263m2022-04-01 → 2022-09-30StandaloneOrdinary income
Profit before tax¥200m2023-04-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax¥263m2022-04-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥135m2023-04-01 → 2023-09-30StandaloneProfit loss
Net income¥383m2022-04-01 → 2023-03-31StandaloneNet income loss (5-year summary)
Net income¥179m2022-04-01 → 2022-09-30StandaloneProfit loss
Total assets¥4.0bnat 2023-09-30StandaloneAssets
Total assets¥2.9bnat 2023-03-31StandaloneAssets
Total assets¥2.8bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥2.4bnat 2023-09-30StandaloneLiabilities
Total liabilities¥1.4bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.6bnat 2023-09-30StandaloneNet assets
Net assets / equity¥1.5bnat 2023-03-31StandaloneNet assets
Net assets / equity¥1.3bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥854mat 2023-09-30StandaloneCash and deposits
Cash and deposits¥568mat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥854mat 2023-09-30StandaloneCash and cash equivalents
Cash & equivalents¥568mat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥680mat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥720mat 2022-03-31dStandaloneCash and cash equivalents
Operating cash flow¥230m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥342m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥97m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥436m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥383m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥193m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥492m2023-04-01 → 2023-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥111m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥57m2022-04-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥18.822023-04-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.722023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.922022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥25.332022-04-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥12.252022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥17.922023-04-01 → 2023-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.822022-04-01 → 2023-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥23.742022-04-01 → 2022-09-30StandaloneDiluted earnings per share (5-year summary)
Equity ratio39.7%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.4%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued7,156,600at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued3,572,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued3,568,400at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥16m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥6m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥230m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2023-04-01 → 2023-09-30¥3.2bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2023-04-01 → 2023-09-30¥298m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2023-04-01 → 2023-09-30¥377m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2023-04-01 → 2023-09-30¥206m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2023-04-01 → 2023-09-30¥288m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2023-04-01 → 2023-09-30−¥67m
—segment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥436m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥431m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥4m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥192m
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentrevenue external2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E37198-000Home Visit Pharmacist Servicereportable segmentsegment profit2022-04-01 → 2022-09-30¥339m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentrevenue external2022-04-01 → 2022-09-30¥275m
jpcrp040300-q2r_E37198-000Kirari Primereportable segmentsegment profit2022-04-01 → 2022-09-30¥144m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentrevenue external2022-04-01 → 2022-09-30¥65m
jpcrp040300-q2r_E37198-000Primary Care Homereportable segmentsegment profit2022-04-01 → 2022-09-30−¥40m
—segment totalrevenue2022-04-01 → 2022-09-30¥3.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥3.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥443m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥447m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Increase decrease in provision for bonuses ope cfCurrentYTDDuration_NonConsolidatedMember-20850000JPY
Interest and dividends income ope cfPrior1YTDDuration_NonConsolidatedMember-3000JPY
Interest and dividends income ope cfCurrentYTDDuration_NonConsolidatedMember-285000JPY
Interest expenses ope cfPrior1YTDDuration_NonConsolidatedMember927000JPY
Interest expenses ope cfCurrentYTDDuration_NonConsolidatedMember1586000JPY
Subsidy income ope cfPrior1YTDDuration_NonConsolidatedMember-9054000JPY
Subsidy income ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration_NonConsolidatedMember-52960000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember-257522000JPY
Decrease increase in inventories ope cfPrior1YTDDuration_NonConsolidatedMember-39612000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember-51632000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration_NonConsolidatedMember18944000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration_NonConsolidatedMember216690000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration_NonConsolidatedMember8707000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration_NonConsolidatedMember11109000JPY
Increase decrease in accrued expenses ope cfPrior1YTDDuration_NonConsolidatedMember10679000JPY
Increase decrease in accrued expenses ope cfCurrentYTDDuration_NonConsolidatedMember48611000JPY
Other net ope cfPrior1YTDDuration_NonConsolidatedMember-6365000JPY
Other net ope cfCurrentYTDDuration_NonConsolidatedMember77699000JPY
Subtotal ope cfPrior1YTDDuration_NonConsolidatedMember188928000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember302336000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration_NonConsolidatedMember3000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration_NonConsolidatedMember3000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration_NonConsolidatedMember-851000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-1681000JPY
Proceeds from subsidy ope cfPrior1YTDDuration_NonConsolidatedMember9054000JPY
Proceeds from subsidy ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Income taxes paid ope cfPrior1YTDDuration_NonConsolidatedMember-100410000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-70275000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration_NonConsolidatedMember96723000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember230382000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration_NonConsolidatedMember-40925000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember-115196000JPY
Purchase of intangible assets inv cfPrior1YTDDuration_NonConsolidatedMember-89563000JPY
Purchase of intangible assets inv cfCurrentYTDDuration_NonConsolidatedMember-16602000JPY
Payments for transfer of business2 inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Payments for transfer of business2 inv cfCurrentYTDDuration_NonConsolidatedMember-40382000JPY
Payments of long term loans receivable inv cfPrior1YTDDuration_NonConsolidatedMember－JPY
Payments of long term loans receivable inv cfCurrentYTDDuration_NonConsolidatedMember-260000000JPY
Payments for lease and guarantee deposits inv cfPrior1YTDDuration_NonConsolidatedMember-62714000JPY
Payments for lease and guarantee deposits inv cfCurrentYTDDuration_NonConsolidatedMember-4281000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YTDDuration_NonConsolidatedMember58000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYTDDuration_NonConsolidatedMember107000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration_NonConsolidatedMember-193145000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember-436354000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember100000000JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember300000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember－JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration_NonConsolidatedMember300000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration_NonConsolidatedMember-69788000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-04-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass